EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities

Dania Al-Sharify iD, Jiangming Sun iD, Andreas Edsfeldt iD

Journal of Internal Medicine · 2026-08 · 300 (2) · 131-152

DOI: 10.1111/joim.70118 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Internal Medicine, online erschienen am 12.06.2026. Verfasst von Dania Al-Sharify und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Atherosclerosis, Diabetic Angiopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hjärt-Lungfonden, Medicinska Fakulteten, Lunds Universitet, Knut och Alice Wallenbergs Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) is a major global health concern strongly associated with atherosclerosis and subsequent macrovascular complications. These complications are the leading cause of death among T2D patients. Despite a decline in cardiovascular events over the last decade, individuals with T2D still have an approximately doubled risk compared to those without diabetes. This shows an urgent need for therapies targeting biological processes specific to T2D‐associated atherosclerosis. Nevertheless, more research is needed to identify exactly which processes can be targeted therapeutically. Current therapies either target lipid metabolism or inflammation, two processes commonly considered important in T2D‐associated atherosclerosis. However, more recent human plaque tissue studies show no differences in plaque levels of lipids nor inflammatory markers, possibly reflecting improved clinical treatment strategies. Other distinct differences in plaque tissue composition in T2D have been put forward, including thin fibrous caps and large necrotic cores. Moreover, T2D may influence several biological processes affecting both plaque formation and progression (such as oxidative stress and efferocytosis). These mechanisms could potentially also be targeted to prevent atherosclerotic cardiovascular complications. This review focuses on the shifting epidemiology of T2D‐associated cardiovascular complications, as well as biological changes in T2D plaques, and how these changes can guide future clinical approaches to further reduce atherosclerotic complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2AtherosclerosisDiabetic AngiopathiesHumansOxidative StressPlaque, Atherosclerotic

Stichwörter der Autor:innen

atherosclerosiscardiovascular complicationsgeneticsimagingtherapiestype 2 diabetes

Autor:innen und Institutionen

  • Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
  • Department of Cardiology, University Hospital of Skåne, Lund/Malmö, Sweden.
  • Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden.

ORCID-Profile: Dania Al-Sharify, Jiangming Sun, Andreas Edsfeldt

Förderung

  • Hjärt-Lungfonden
  • Medicinska Fakulteten, Lunds Universitet
  • Knut och Alice Wallenbergs Stiftelse
  • Stiftelsen Bundy Academy
  • Skånes universitetssjukhus
  • Hjelt Foundations
  • the Swedish Stroke Association
  • Vetenskapsrådet

Zitieren

APA

Al-Sharify, D., Sun, J., & Edsfeldt, A. (2026). The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities. Journal of Internal Medicine, 300(2), 131-152. https://doi.org/10.1111/joim.70118

Vancouver

Al-Sharify D, Sun J, Edsfeldt A. The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities. Journal of Internal Medicine. 2026;300(2):131-152. doi:10.1111/joim.70118

BibTeX
@article{AlSharify2026,
  author = {Al-Sharify, Dania and Sun, Jiangming and Edsfeldt, Andreas},
  title = {The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities},
  journal = {Journal of Internal Medicine},
  year = {2026},
  volume = {300},
  number = {2},
  pages = {131--152},
  doi = {10.1111/joim.70118}
}
Kostenlos starten →